NASDAQ: MRNA - Moderna

Rentabilité sur six mois: -54.62%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Nouvelles Télégramme

China approves Livzon Pharmaceutical's COVID vaccine as a booster

18 novembre 18:22 China approves Livzon Pharmaceutical's COVID vaccine as a booster

CDC approves updated COVID-19 vaccines targeting omicron variant

18 novembre 18:14 CDC approves updated COVID-19 vaccines targeting omicron variant

Moderna stock tumbles after quarterly earnings show revenue declines

18 novembre 18:05 Moderna stock tumbles after quarterly earnings show revenue declines

Moderna says updated COVID-19 vaccine offers 'strong immune response' to new variant

18 novembre 18:03 Moderna says updated COVID-19 vaccine offers 'strong immune response' to new variant

FDA panel recommends Pfizer and Moderna COVID-19 vaccines for children as young as 6 months old

18 novembre 17:47 FDA panel recommends Pfizer and Moderna COVID-19 vaccines for children as young as 6 months old

Vaccine makers see stock price boost on Biden admin COVID shot push

18 novembre 17:29 Vaccine makers see stock price boost on Biden admin COVID shot push

Moderna looks to inspire ‘revolution’ in cancer treatments: CEO

18 novembre 16:57 Moderna looks to inspire ‘revolution’ in cancer treatments: CEO

U.S. begins rolling out COVID vaccines for young children

18 novembre 16:57 U.S. begins rolling out COVID vaccines for young children

Aflac CEO says company adapted to health care in a 'post-COVID world'

18 novembre 16:52 Aflac CEO says company adapted to health care in a 'post-COVID world'

Pfizer shares sink after it resets 2024 COVID expectations

18 novembre 16:37 Pfizer shares sink after it resets 2024 COVID expectations